BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6432998)

  • 1. Rapid gas chromatographic assay for monitoring valproic acid and valpromide in plasma.
    Bialer M; Friedman M; Rubinstein A
    J Pharm Sci; 1984 Jul; 73(7):991-3. PubMed ID: 6432998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and simple GLC determination of valproic acid and ethosuximide in plasma of epileptic patients.
    Riva R; Albani F; Baruzzi A
    J Pharm Sci; 1982 Jan; 71(1):110-1. PubMed ID: 6799640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay for valproic acid and its E-delta2 metabolite in rat plasma by capillary gas chromatography without prior derivatization.
    Carlin A; Simmons J
    J Chromatogr B Biomed Sci Appl; 1997 Jun; 694(1):115-21. PubMed ID: 9234854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved gas chromatographic determination of valproic acid and valpromide in plasma.
    Pokrajac M; Miljković B; Spiridonović D; Varagić VM
    Pharm Acta Helv; 1992; 67(8):237-40. PubMed ID: 1409759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple, direct extraction method for gas-liquid chromatographic determination of valproic acid in plasma.
    Odusote KA; Sherwin AL
    Ther Drug Monit; 1981; 3(1):103-6. PubMed ID: 6785904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid.
    Rettenmeier AW; Gordon WP; Prickett KS; Levy RH; Baillie TA
    Drug Metab Dispos; 1986; 14(4):454-64. PubMed ID: 2873993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved gas liquid chromatographic assay for plasma valproic acid concentrations in mentally handicapped epileptic children.
    Chan K; Teoh R; Lok S
    Methods Find Exp Clin Pharmacol; 1985 Nov; 7(11):589-93. PubMed ID: 3937004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of valproic acid (di-N-propyl acetic acid) in plasma by gas-liquid chromatography with pre-column butylation.
    Hulshoff A; Roseboom H
    Clin Chim Acta; 1979 Apr; 93(1):9-13. PubMed ID: 373927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of valpromide in dogs after various modes of administration.
    Bialer M; Rubinstein A
    Biopharm Drug Dispos; 1984; 5(2):177-83. PubMed ID: 6430363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gas chromatographic method for the determination of valproic acid in human plasma.
    Hershey AE; Patton JR; Dudley KH
    Ther Drug Monit; 1979; 1(2):217-41. PubMed ID: 122159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five doubly unsaturated metabolites of valproic acid in urine and plasma of patients on valproic acid therapy.
    Kochen W; Sprunck HP; Tauscher W; Klemens M
    J Clin Chem Clin Biochem; 1984 Apr; 22(4):309-17. PubMed ID: 6429268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teratogenicity of valproic acid and related substances in the mouse: drug accumulation and pHi in the embryo during organogenesis and structure-activity considerations.
    Nau H; Scott WJ
    Arch Toxicol Suppl; 1987; 11():128-39. PubMed ID: 3115230
    [No Abstract]   [Full Text] [Related]  

  • 13. Simple gas-chromatographic measurement of valproic acid in psychiatric patients: effect on levels of other simultaneously administered anticonvulsants.
    Varma R; Hoshino AY
    Neurosci Lett; 1979 Mar; 11(3):353-6. PubMed ID: 390426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of valproic acid in human serum and pharmaceutical preparations by headspace liquid-phase microextraction gas chromatography-flame ionization detection without prior derivatization.
    Shahdousti P; Mohammadi A; Alizadeh N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):128-33. PubMed ID: 17157566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of plasma levels of valproic acid (dipropylacetic acid) by gas chromatography].
    Tsanaclis LM; Garcia TG
    Arq Neuropsiquiatr; 1981 Sep; 39(3):301-5. PubMed ID: 6798957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of relationship between sodium valproate-induced adverse effects and the plasma concentration of its metabolite 2-propylpenten-4-oic acid.
    Paganini M; Zaccara G; Moroni F; Campostrini R; Bendoni L; Arnetoli G; Zappoli R
    Eur J Clin Pharmacol; 1987; 32(2):219-22. PubMed ID: 3108013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capillary gas chromatographic assay for valproic acid and its 2-desaturated metabolite in brain and plasma.
    Semmes RL; Shen DD
    J Chromatogr; 1988 Nov; 432():185-97. PubMed ID: 3146579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capillary GCMS assay of 2-n-propyl-4-pentenoic acid (4-ene VPA) in rat plasma and urine.
    Singh K; Abbott FS; Orr JM
    Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):211-23. PubMed ID: 3602586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of valproic acid (dipropylacetic acid) in plasma by gas-liquid chromatography.
    Berry DJ; Clarke LA
    J Chromatogr; 1978 Sep; 156(2):301-7. PubMed ID: 359583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid and sensitive gas-liquid chromatographic procedure for the micro determination of sodium valproate (sodium di-N-propylacetate) in plasma or serum.
    Fellenberg AJ; Pollard AC
    Clin Chim Acta; 1977 Dec; 81(2):203-8. PubMed ID: 338203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.